Validation of self-reported medication use for hypertension, diabetes, and dyslipidemia among employees of large-sized companies in Japan.
Kota FukaiTomohisa NagataKoji MoriMakoto OhtaniKenji FujimotoMasako NagataYoshihisa FujinoPublished in: Journal of occupational health (2020)
This validation of self-reported medication use for hypertension, diabetes, and dyslipidemia showed almost perfect reliability among employees of large-sized companies in Japan.